Diagnostic tests to mitigate the antimicrobial resistance pandemic-Still the problem child.
作者信息
Ferreyra Cecilia, Gleeson Birgitta, Kapona Otridah, Mendelson Marc
机构信息
FIND, Geneva, Switzerland.
Zambia National Public Health Institute, Lusaka, Zambia.
出版信息
PLOS Glob Public Health. 2022 Jun 30;2(6):e0000710. doi: 10.1371/journal.pgph.0000710. eCollection 2022.
Abstract
摘要
相似文献
1
Diagnostic tests to mitigate the antimicrobial resistance pandemic-Still the problem child.
PLOS Glob Public Health. 2022 Jun 30;2(6):e0000710. doi: 10.1371/journal.pgph.0000710. eCollection 2022.
2
COVID-19 pandemic and antimicrobial resistance in developing countries.
Discoveries (Craiova). 2021 Jun 30;9(2):e127. doi: 10.15190/d.2021.6. eCollection 2021 Apr-Jun.
3
Antimicrobial Resistance: The Next Probable Pandemic.
JNMA J Nepal Med Assoc. 2022 Feb 15;60(246):225-228. doi: 10.31729/jnma.7174.
4
Multidrug resistance crisis during COVID-19 pandemic: Role of anti-microbial peptides as next-generation therapeutics.
Colloids Surf B Biointerfaces. 2022 Mar;211:112303. doi: 10.1016/j.colsurfb.2021.112303. Epub 2021 Dec 20.
5
Operational challenges of the Philippine Antimicrobial Resistance Surveillance Program during the COVID-19 pandemic.
Western Pac Surveill Response J. 2022 Aug 25;13(3):1-6. doi: 10.5365/wpsar.2022.13.3.917. eCollection 2022 Jul-Sep.
6
Challenges to Antimicrobial Stewardship in the Countries of the Arab League: Concerns of Worsening Resistance during the COVID-19 Pandemic and Proposed Solutions.
Antibiotics (Basel). 2021 Oct 29;10(11):1320. doi: 10.3390/antibiotics10111320.
7
Implications of COVID-19 Pandemic on the Emergence of Antimicrobial Resistance: Adjusting the Response to Future Outbreaks.
Life (Basel). 2021 Mar 10;11(3):220. doi: 10.3390/life11030220.
8
Antimicrobial resistance: new insights and therapeutic implications.
Appl Microbiol Biotechnol. 2022 Oct;106(19-20):6427-6440. doi: 10.1007/s00253-022-12175-8. Epub 2022 Sep 19.
9
Antimicrobial resistance research in a post-pandemic world: Insights on antimicrobial resistance research in the COVID-19 pandemic.
J Glob Antimicrob Resist. 2021 Jun;25:5-7. doi: 10.1016/j.jgar.2021.02.013. Epub 2021 Mar 1.
10
Flare of the silent pandemic in the era of the COVID-19 pandemic: Obstacles and opportunities.
World J Clin Cases. 2023 Feb 26;11(6):1267-1274. doi: 10.12998/wjcc.v11.i6.1267.
引用本文的文献
1
A novel machine-learning aided platform for rapid detection of urine ESBLs and carbapenemases: URECA-LAMP.
J Clin Microbiol. 2024 Nov 13;62(11):e0086924. doi: 10.1128/jcm.00869-24. Epub 2024 Oct 24.
2
New Agents Are Coming, and So Is the Resistance.
Antibiotics (Basel). 2024 Jul 13;13(7):648. doi: 10.3390/antibiotics13070648.
3
Cost-effectiveness of point-of-care diagnostics for AMR: a systematic review.
J Antimicrob Chemother. 2024 Jun 3;79(6):1248-1269. doi: 10.1093/jac/dkae067.
4
Novel lateral flow assay for point-of-care detection of Neisseria gonorrhoeae infection in syndromic management settings: a cross-sectional performance evaluation.
Lancet. 2024 Feb 17;403(10427):657-664. doi: 10.1016/S0140-6736(23)02240-7. Epub 2024 Feb 6.
本文引用的文献
1
Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.
Lancet. 2022 Feb 12;399(10325):629-655. doi: 10.1016/S0140-6736(21)02724-0. Epub 2022 Jan 19.
2
C-reactive protein as an early biomarker for malaria infection and monitoring of malaria severity: a meta-analysis.
Sci Rep. 2021 Nov 11;11(1):22033. doi: 10.1038/s41598-021-01556-0.
3
The role of C-reactive protein in predicting the severity of COVID-19 disease: A systematic review.
SAGE Open Med. 2021 Oct 11;9:20503121211050755. doi: 10.1177/20503121211050755. eCollection 2021.
4
The Lancet Commission on diagnostics: transforming access to diagnostics.
Lancet. 2021 Nov 27;398(10315):1997-2050. doi: 10.1016/S0140-6736(21)00673-5. Epub 2021 Oct 6.
5
Sales of antibiotics and hydroxychloroquine in India during the COVID-19 epidemic: An interrupted time series analysis.
PLoS Med. 2021 Jul 1;18(7):e1003682. doi: 10.1371/journal.pmed.1003682. eCollection 2021 Jul.
6
Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study.
Lancet Microbe. 2021 Aug;2(8):e354-e365. doi: 10.1016/S2666-5247(21)00090-2. Epub 2021 Jun 2.
7
Role of C- reactive proteins and liver function tests in assessing the severity of dengue fever.
J Pak Med Assoc. 2021 Mar;71(3):810-815. doi: 10.47391/JPMA.170.
8
Enhanced antibiotic resistance as a collateral COVID-19 pandemic effect?
J Hosp Infect. 2021 Jan;107:114-115. doi: 10.1016/j.jhin.2020.11.010. Epub 2020 Nov 17.
9
Procalcitonin levels in COVID-19 patients.
Int J Antimicrob Agents. 2020 Aug;56(2):106051. doi: 10.1016/j.ijantimicag.2020.106051. Epub 2020 Jun 10.
10
Coronavirus Disease 2019, Superinfections, and Antimicrobial Development: What Can We Expect?
Clin Infect Dis. 2020 Dec 17;71(10):2736-2743. doi: 10.1093/cid/ciaa524.
Zotero 插件